Biologics have become a novel treatment in recurrent C. difficile.
Helen G. Berhane, PharmD, and Jennifer N. Curello, PharmD, BCIDP
Advertisement
Articles by Helen G. Berhane, PharmD, and Jennifer N. Curello, PharmD, BCIDP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Is 4 Weeks of Glecaprevir/Pibrentasvir Sufficient to Treat Early Hepatitis C Infection?
2
Antibiotic Shows Promise in Treating Gram-Positive Pneumonia, Including in High-Risk Patients
3
Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance
4
As NDM-CRE Infections Rise Significantly, Diagnostic Access Emerges as Weak Link
5
